CN105288029A - Medicine for treating pelvic inflammation - Google Patents
Medicine for treating pelvic inflammation Download PDFInfo
- Publication number
- CN105288029A CN105288029A CN201510909943.0A CN201510909943A CN105288029A CN 105288029 A CN105288029 A CN 105288029A CN 201510909943 A CN201510909943 A CN 201510909943A CN 105288029 A CN105288029 A CN 105288029A
- Authority
- CN
- China
- Prior art keywords
- medicine
- rhizoma
- grams
- weight
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention aims to provide a medicine for treating pelvic inflammation. A preparation method of the medicine comprises the following steps: carrying out flowing steam sterilization on angelica, nutgrass galingale rhizome, corydalis tuber, moutan bark, rhizoma alismatis, toosendan fruit, forsythia, honeysuckle and patrinia according to parts by weight, baking and then mixing, crushing into medicinal powder of more than 100 meshes, and encapsulating. The medicine is prepared from traditional Chinese medicines, has the effects of clearing away heat and promoting diuresis, warming channels and expelling cold, promoting flow of qi and blood circulation as well as cooling blood and eliminating toxins, and achieves the purposes of high effect taking speed, small side effect and no recurrence when being used for treating pelvic inflammation.
Description
Technical field
The invention belongs to the field of Chinese medicines, particularly relate to a kind of medicine taking Chinese medicine as crude drug and treat pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease refers to female pelvic cavity genitals, periuterine connective tissue and pelvic peritoneal inflammation, belong to traditional Chinese medical science “ mass in the abdomen ", " leukorrhagia ", categories such as " damp invasion of lower energizer ", the clinical cold-damp that is divided into is condensed, damp invasion of lower energizer, stagnation of QI-blood, damp and hot strongly fragrant poison, scorchingly hot one-tenth pus etc., it is one of common gynaecopathia, patients symptomatic's main manifestations is lower abdominal pain, pain in the lumbar region, leucorrhea is many, there is enclosed mass, occurring in property active phase mostly, relevant with bacteriological infection with the body constitution of women, the western medicine antibiotics class medicine that adopts is treated more now, but poor effect, easy generation drug resistance.
Summary of the invention
The object of this invention is to provide a kind of medicine being used for the treatment of pelvic inflammatory disease, this medicine is made up of the effect with clearing away heat-damp and promoting diuresis, warm born of the same parents' cold expelling, promoting flow of QI and blood, removing pathogenic heat from blood and toxic substance from the body Chinese medicine, can play that instant effect, side effect are little, not object repeatedly to the treatment of pelvic inflammatory disease.
A kind of medicine being used for the treatment of pelvic inflammatory disease of the present invention is that crude drug prepares by the Chinese medicine of following parts by weight:
Radix Angelicae Sinensis 5 ~ 15, Rhizoma Cyperi 4 ~ 6, Rhizoma Corydalis 4 ~ 6,
Cortex Moutan 4 ~ 6, Rhizoma Alismatis 5 ~ 15, Fructus Toosendan 5 ~ 15,
Fructus Forsythiae 5 ~ 15, Flos Lonicerae 5 ~ 15, Herba Patriniae 5 ~ 15.
Preferably, the medicine being used for the treatment of pelvic inflammatory disease of the present invention is be that crude drug prepares by the Chinese medicine of following parts by weight: Radix Angelicae Sinensis 10, Rhizoma Cyperi 5, Rhizoma Corydalis 5, Cortex Moutan 5, Rhizoma Alismatis 10, Fructus Toosendan 10, Fructus Forsythiae 10, Flos Lonicerae 10, Herba Patriniae 10.
Medicine of the present invention can make any peroral dosage form on pharmaceutics, the preferred capsule of the present invention.
The preparation method of medicine capsule product of the present invention is, by Radix Angelicae Sinensis, Rhizoma Cyperi, Rhizoma Corydalis, Cortex Moutan, Rhizoma Alismatis, Fructus Toosendan, Fructus Forsythiae, Flos Lonicerae, Herba Patriniae, according to described parts by weight through flowing steam sterilization, mixing after drying, be ground into the medicated powder of more than 100 orders, incapsulate and get final product.
In prescription of the present invention, Radix Angelicae Sinensis is sweet, pungent, warm, return liver, the heart, spleen channel, enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, moisturize laxation, the all cards of main blood deficiency, menoxenia, amenorrhea, dysmenorrhea, for weight, ulcer sores, injury from falling down after blood deficiency dull yellowish colored skin, dizzy cardiopalmus, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, numbness of the skin, dryness of the intestine dyschezia, bloody dysentery; Pungent, the micro-hardship of Rhizoma Cyperi, micro-sweet, flat, return liver, spleen, tri-jiao channel, dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving, distension pain vexed for stagnation of QI due to depression of the liver, distending pain in the chest and hypochondrium, hernia pain, distending pain of the breast, stagnation of QI in spleen and stomach, gastral cavity abdomen painful abdominal mass, menoxenia, amenorrhea dysmenorrhea; Rhizoma Corydalis acrid in the mouth, hardship, warm in nature, enter lung, liver, spleen channel, have the function of promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving, for whole body each portion qi depression to blood stasis, pain, dysmenorrhea, amenorrhea, lump in the abdomen, postpartum stagnation, injury from falling down, hernia are had a pain; Cortex Moutan is bitter, pungent, be slightly cold, and GUIXIN, liver, kidney channel, have the effects such as clearing away heat and cooling blood, activating blood circulation to dissipate blood stasis, reducing the asthenic fever; Rhizoma Alismatis sweet in the mouth, light, cold in nature, return kidney, urinary bladder channel, promoting diuresis to eliminate damp pathogen, expel the heat-evil, change turbid blood fat reducing, for dysuria, edema distension, oliguria of having loose bowels, dizziness due to fluid-retention, the puckery pain of pyretic stranguria, hyperlipemia; Fructus Toosendan is bitter, cold, returns liver, small intestinal, urinary bladder channel, soothing the liverly to expel the heat-evil, promoting the circulation of QI to relieve pain, parasite killing, for pathogenic fire derived from stagnation of liver-QI, the breast side of body, abdominal distention, hernia pain, abdominal pain due to worm stagnation; Fructus Forsythiae is bitter, cool, enters the heart, liver, gallbladder meridian, heat clearing away, removing toxic substances, eliminating stagnation, detumescence, controls warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula, urine stranguria with urinary obstruction; Flos Lonicerae is cold in nature, sweet in the mouth, enters lung, the heart, stomach warp, has heat-clearing and toxic substances removing, antiinflammatory, tonify deficiency treat effect of wind, cures mainly disease under distension, epidemic febrile disease heating, the diseases such as pyretic toxicity carbuncle and ulcer and tumor; Its nature and flavor of Herba Patriniae are pungent, bitter, be slightly cold, and have the merit of heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, stasis-dispelling and pain-killing.All medicine compatibilities, clearing away heat-damp and promoting diuresis, warm born of the same parents' cold expelling, promoting flow of QI and blood, removing pathogenic heat from blood and toxic substance from the body, to acute and chronic pelvic inflammation, Be very effective.
Capsule medicine of the present invention, also has following characteristics:
Capsule medicine had both protected the medicine property of medicine and be not destroyed, and also protected digestive organs and respiratory tract.
For investigating clinical efficacy and the safety of capsule medicine of the present invention further, 135 routine Patients with Pelvic Inflammatory Diseases are selected to carry out clinical observation to the curative effect of medicine of the present invention.
In 135 routine cases, 20 ~ 56 years old age female patient, the course of disease 3 ~ 24 months, is divided into three groups often to organize 45 examples at random, and three groups of cases through statistical analysis no significant difference, have comparability in age etc.
Diagnostic criteria
Efficacy assessment standard with reference to chronic pelvic inflammatory disease diagnostic criteria in " new Chinese medicine guideline of clinical investigations " is formulated,
Cardinal symptom has hypogastric region falling inflation, pain and lumbosacral region to ache, leucorrhoea grow in quantity; Some patients have menoxenia or infertile history; Retroposition of uterus is shown in gynecologial examination, movable poor, has tenderness, and side or bilateral adnexa have thickened tenderness or be that streak increasing is thick, or have enclosed mass, tenderness; Pelvic malignant and endometriosis is got rid of through B ultrasonic and lab testing.
Therapeutic Method
Three groups each 45 example, accept respectively embodiment 1, embodiment 2, embodiment 3 capsule carry out clinical treatment.Usage and dosage: oral, one time 5 ~ 6,2 ~ 3 times on the one, menstrual phase and anemia of pregnant woman person forbidding, avoid maror at period in a medicine.
Criterion of therapeutical effect
Cure: treatment after the transference cure such as hypogastralgia and waist sacrum distending pain, gynecologial examination and physico-chemical examination normal.Effective: treat the rear transference cure such as hypogastralgia and waist sacrum distending pain or obviously alleviate, gynecologial examination and physico-chemical examination obviously improve.Effective: after treatment, the symptom such as hypogastralgia and waist sacrum distending pain alleviates, and gynecologial examination and physico-chemical examination make moderate progress.Invalid: after treatment, the symptom such as hypogastralgia and waist sacrum distending pain increases the weight of without alleviating or having, gynecologial examination and physico-chemical examination increase the weight of without improving or having before comparatively treating.
After three groups of case treatments, comparitive study statistical result is as follows:
Detailed description of the invention
Embodiment 1
Get Radix Angelicae Sinensis 300 grams, Rhizoma Cyperi 150 grams, Rhizoma Corydalis 150 grams, Cortex Moutan 150 grams, Rhizoma Alismatis 300 grams, Fructus Toosendan 300 grams, Fructus Forsythiae 300 grams, Flos Lonicerae 300 grams, Herba Patriniae 300 grams, through flowing steam sterilization, mixing after drying at 35 DEG C, grinding and processing becomes the medicated powder of more than 100 orders.Load 2# capsule.Every loading amount 0.25 gram.
Embodiment 2
Get Radix Angelicae Sinensis 150 grams, Rhizoma Cyperi 120 grams, Rhizoma Corydalis 120 grams, Cortex Moutan 120 grams, Rhizoma Alismatis 150 grams, Fructus Toosendan 150 grams, Fructus Forsythiae 150 grams, Flos Lonicerae 150 grams, Herba Patriniae 150 grams, through flowing steam sterilization, mixing after drying at 40 DEG C, grinding and processing becomes the medicated powder of more than 100 orders.Load 2# capsule.Every loading amount 0.26 gram.
Embodiment 3
Get Radix Angelicae Sinensis 450 grams, Rhizoma Cyperi 180 grams, Rhizoma Corydalis 180 grams, Cortex Moutan 180 grams, Rhizoma Alismatis 450 grams, Fructus Toosendan 450 grams, Fructus Forsythiae 450 grams, Flos Lonicerae 450 grams, Herba Patriniae 450 grams, through flowing steam sterilization, mixing after drying at 50 DEG C, grinding and processing becomes the medicated powder of more than 100 orders.Load 2# capsule.Every loading amount 0.27 gram.
Claims (3)
1. being used for the treatment of a medicine for pelvic inflammatory disease, is be that crude drug prepares by the Chinese medicine of following parts by weight:
Radix Angelicae Sinensis 5 ~ 15, Rhizoma Cyperi 4 ~ 6, Rhizoma Corydalis 4 ~ 6,
Cortex Moutan 4 ~ 6, Rhizoma Alismatis 5 ~ 15, Fructus Toosendan 5 ~ 15,
Fructus Forsythiae 5 ~ 15, Flos Lonicerae 5 ~ 15, Herba Patriniae 5 ~ 15.
2. the medicine being used for the treatment of pelvic inflammatory disease according to claim 1, is characterized in that: be that crude drug prepares by the Chinese medicine of following parts by weight: Radix Angelicae Sinensis 10, Rhizoma Cyperi 5, Rhizoma Corydalis 5, Cortex Moutan 5, Rhizoma Alismatis 10, Fructus Toosendan 10, Fructus Forsythiae 10, Flos Lonicerae 10, Herba Patriniae 10.
3. a kind of preparation method being used for the treatment of the medicine of pelvic inflammatory disease according to claim 1 is, by Radix Angelicae Sinensis, Rhizoma Cyperi, Rhizoma Corydalis, Cortex Moutan, Rhizoma Alismatis, Fructus Toosendan, Fructus Forsythiae, Flos Lonicerae, Herba Patriniae, according to described parts by weight through flowing steam sterilization, mixing after drying, be ground into the medicated powder of more than 100 orders, incapsulate and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510909943.0A CN105288029A (en) | 2015-12-10 | 2015-12-10 | Medicine for treating pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510909943.0A CN105288029A (en) | 2015-12-10 | 2015-12-10 | Medicine for treating pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105288029A true CN105288029A (en) | 2016-02-03 |
Family
ID=55186307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510909943.0A Pending CN105288029A (en) | 2015-12-10 | 2015-12-10 | Medicine for treating pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105288029A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104107280A (en) * | 2014-07-03 | 2014-10-22 | 赵兰 | Pharmaceutical composition for treating chronic pelvic inflammation, and preparation method and application thereof |
| CN104383203A (en) * | 2014-10-17 | 2015-03-04 | 王怀喜 | Traditional Chinese medicine preparation for treating pelvic inflammation |
| CN105362577A (en) * | 2015-12-09 | 2016-03-02 | 赵爱良 | Navel patch for treating pelvic inflammation and preparation method thereof |
-
2015
- 2015-12-10 CN CN201510909943.0A patent/CN105288029A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104107280A (en) * | 2014-07-03 | 2014-10-22 | 赵兰 | Pharmaceutical composition for treating chronic pelvic inflammation, and preparation method and application thereof |
| CN104383203A (en) * | 2014-10-17 | 2015-03-04 | 王怀喜 | Traditional Chinese medicine preparation for treating pelvic inflammation |
| CN105362577A (en) * | 2015-12-09 | 2016-03-02 | 赵爱良 | Navel patch for treating pelvic inflammation and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 付晓: "中西医结合治疗246例慢性盆腔炎临床治疗观察", 《中外医疗》 * |
| 郑玉燕等: "自拟消炎汤治疗慢性盆腔炎湿热瘀阻型65例疗效观察", 《中国社区医师（医学专业半月刊）》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
| CN100586468C (en) | Chinese medicine for treating hepatitis B | |
| CN105535715A (en) | Traditional Chinese medicine skin-wash liquid for treating hot and damp eczema | |
| CN105327205A (en) | Traditional Chinese medicine preparation for treating thyroid cancer | |
| CN104784673A (en) | Traditional Chinese medicine navel paste for treating infantile diarrhea | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN101879288A (en) | Chinese medicinal formula for treating hydronephrosis | |
| CN1895434B (en) | Medicine for treating hysteromyoma | |
| CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
| CN104623220A (en) | Traditional Chinese medicine composition for treating acute mastitis and application of traditional Chinese medicine composition | |
| CN104547685A (en) | Traditional Chinese medicine preparation for treating kidney stone and urinary stone | |
| CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN101953930B (en) | Externally-applied traditional Chinese medicine for treating tinea capitis | |
| CN104784489B (en) | A kind of chronic cervicitis for the treatment of merges the Chinese medicine preparation of HPV infection | |
| CN103127427B (en) | Chinese medicinal composition for treating chronic pelvic inflammation | |
| CN105816813A (en) | Medicine composition for treating breast cancer and preparing method and application of medicine composition | |
| CN100371016C (en) | Chinese traditional medicine preparation for curing mastopathy in installments | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN105288029A (en) | Medicine for treating pelvic inflammation | |
| CN103845547A (en) | Traditional Chinese medicine decoction for treating mumps | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN105362577A (en) | Navel patch for treating pelvic inflammation and preparation method thereof | |
| CN102688453A (en) | Traditional Chinese medicine composite for treating breast cancer | |
| CN107441292A (en) | It is a kind of to be used to treat powder agent medicine of chronic prostatitis and preparation method thereof | |
| CN101869629B (en) | Traditional Chinese medicine for treating renal calculus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160203 |
|
| WD01 | Invention patent application deemed withdrawn after publication |